Level Four Advisory Services’s Jupiter Neurosciences JUNS Stock Holding History

Level Four Advisory Services’s Portfolio JUNS Stock Details JUNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.14K	Buy	+133	New	+$3.15K	﹤0.01%	935

Other funds holding JUNS

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vestor Capital Chicago, Illinois $1.59M AUM 51.04% 1-Year Est. Return

MidFirst Bank Oklahoma City, Oklahoma $1.41B AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Level Four Advisory Services's JUNS Position: Q2 2026 in Review

Level Four Advisory Services opened a new position in Jupiter Neurosciences (JUNS) in Q2 2026: 133 shares worth $2.14K. The stake represents ﹤0.01% of the portfolio and ranks #935 among its holdings.

11 funds tracked by Wall St. Rank hold JUNS as of Q2 2026.

Level Four Advisory Services held 133 shares of Jupiter Neurosciences worth $2.14K as of Q2 2026.
Jupiter Neurosciences was a new Level Four Advisory Services position in Q2 2026.
Jupiter Neurosciences made up ﹤0.01% of Level Four Advisory Services's portfolio in Q2 2026, its #935 holding.
11 funds tracked by Wall St. Rank held Jupiter Neurosciences as of Q2 2026.

Based on Level Four Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.